Selected article for: "abnormality liver function and liver function"

Author: Li, Shasha; Li, Jinsong; Zhang, Zhenhua; Tan, Lin; Shao, Tuo; Li, Ming; Li, Xiuyong; Holmes, Jacinta A.; Lin, Wenyu; Han, Mingfeng
Title: COVID-19 induced liver function abnormality associates with age
  • Cord-id: a0z4xmxj
  • Document date: 2020_7_28
  • ID: a0z4xmxj
    Snippet: Background: Coronavirus disease 2019 (COVID-19) is a novel infectious disease that may cause fever, dry cough, fatigue and shortness of breath. The impact of COVID-19 on liver function is not well described. Results: We found that the overall frequency of LFT abnormality was 17.6%. Frequency of LFT abnormality was significantly greater in patients with severe/critical (SC) COVID-19 compared to those with mild/moderate (MM) COVID-19 (32.4% vs 11.6%, p=0.011). Among patients with LFT abnormality,
    Document: Background: Coronavirus disease 2019 (COVID-19) is a novel infectious disease that may cause fever, dry cough, fatigue and shortness of breath. The impact of COVID-19 on liver function is not well described. Results: We found that the overall frequency of LFT abnormality was 17.6%. Frequency of LFT abnormality was significantly greater in patients with severe/critical (SC) COVID-19 compared to those with mild/moderate (MM) COVID-19 (32.4% vs 11.6%, p=0.011). Among patients with LFT abnormality, the median age was significantly higher in the SC group compared to the MM group (52 vs 39 years, p=0.021). Conclusion: COVID-19 is frequently associated with mild liver function abnormality, particularly in individuals with severe/critical COVID-19 who were older. Liver function should be monitored carefully during infection, with judicious use of hepatotoxic agents where possible and avoidance of prolonged hypotension to minimize liver injury in older patients. Methods: The No. 2 People’s Hospital of Fuyang City in China has admitted a total of 159 patients with confirmed COVID-19 since the outbreak from January 2020 to March 2020. We analyzed the incidence of liver function test (LFT) abnormality in these patients with confirmed COVID-19 infection.

    Search related documents:
    Co phrase search for related documents
    • abdominal pain and admission follow: 1
    • abdominal pain and admission week: 1, 2, 3, 4
    • abdominal pain and liver damage: 1, 2, 3, 4, 5, 6, 7, 8
    • abdominal pain and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
    • abdominal pain and liver dysfunction: 1, 2, 3, 4
    • abdominal pain and liver enzyme: 1, 2, 3, 4, 5, 6, 7, 8
    • abdominal pain and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • abdominal pain and liver function test: 1
    • abdominal pain and liver impairment: 1, 2, 3, 4
    • abdominal pain and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • abdominal pain and liver involvement: 1, 2, 3, 4, 5, 6, 7, 8
    • abdominal pain and liver synthetic: 1
    • abdominal pain and liver synthetic function: 1
    • abdominal pain and liver tissue: 1
    • abdominal pain and lopinavir hydroxychloroquine ritonavir: 1, 2
    • abdominal pain and lopinavir ritonavir: 1, 2, 3, 4
    • abdominal pain and low respiratory rate: 1
    • abdominal pain and lung tissue: 1, 2
    • abnormal alp and liver damage: 1